NEW YORK (GenomeWeb News) — Bio-Rad Laboratories will pay Ciphergen $2 million once the US Patent and Trademark Office re-issues a SELDI mass-spectrometry-related patent, Ciphergen said yesterday.
Ciphergen said the USPTO has given it a notice of intent to issue a Re-examination Certificate for the patent, entitled “Method and apparatus for desorption and ionization of analytes” and assigned to the Baylor College of Medicine.

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

University of California, San Diego, researchers have developed a gene drive to control a fruit-destroying fly.

A new study of a β-thalassemia gene therapy appears promising, according to NPR.

In Nature this week: hair color genes, hybridization between 13-year and 17-year cicadas, and more.

Futurism writes that gene doping could be the next generation of cheating in sports.